Values
Our identity
Consumer protection
Employees & partners
Mission
Environment
Code of conduct
Whistleblowing
Corporate compliance
Policy for the
Prevention of Corruption
Sustainability report
Benefit Company - B Corp
Kip for social
Corporate
Innovative PMI
Nutraceuticals
Profile and organization
Research and development
Company validations
Product certifications
and Declarations
Patents
Trademarks
KIP Academy
Quality & protection
Raw materials choice
Attention to food intolerances
Study about the packs
Information in braille
Tamper Evident system
Conservation and transportation
The nutraceutic module
Products
All products
Neurological Line
Kymax
®
Declinex
®
Uro-Gynecological Line
KIPFeR
®
Almetax
®
Almetax Easy
®
Ivuxur
®
sachets
Ivuxur
®
tablets
Miledix
®
Xinprox
®
Osteoarticular line
Dolatrox
®
Milesax
®
Xinepa
®
Xinepa Easy
®
Doltendix
®
Immunological Line
KIP
®
IMMUNO
Other products
Dolatrox hcc
®
Media
News
Press review
Press kit
Contact Media Relations
Contact
For consumers
For doctors
For pharmacies and health stores
For distributors
For other subjects
Work with us
Where we are
Legal notice
Privacy
E-commerce
Language
Italiano
English
Press review
News from the world KOLINPHARMA
20/03/2024
-
published at 15.27
KOLINPHARMA
®
expands the range of products with the launch of Kymax
®
In recent decades, world demographics have changed significantly with a progressive aging of the global population.
10/01/2024
-
published at 14.45
Kolinpharma® launches KIPFeR® following agreement with Nemysis LTD
Kipfer is the new dietary supplement designed for all situations in which the body is deficient in iron.
Media
News
Press review
Press Kit
Contact media relations
“Science accuracy and listen to people”
“Science accuracy and listen to people”
Language
